Aluminum phosphate
Showing 1 - 25 of 1,082
Cholera Vaccination Reaction Trial in Seoul (OSP:rTTHc Cholera Conjugate Vaccine Cohort A, OSP:rTTHc Cholera Conjugate Vaccine
Recruiting
- Cholera Vaccination Reaction
- OSP:rTTHc Cholera Conjugate Vaccine Cohort A
- +8 more
-
Seoul, Korea, Republic of
- +2 more
Nov 30, 2022
Respiratory Syncytial Viruses Trial in Australia (RSV F Vaccine with Aluminum Phosphate Adjuvant, RSV F Vaccine, Matrix-M1
Completed
- Respiratory Syncytial Viruses
- RSV F Vaccine with Aluminum Phosphate Adjuvant
- +3 more
-
Sydney, New South Wales, Australia
- +4 more
Dec 2, 2021
COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)
Not yet recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901e
-
Halifax, Nova Scotia, Canada
- +3 more
Dec 10, 2022
HIV Trial in Bangkok (IHV01, A244, ALFQ)
Recruiting
- HIV
- IHV01
- +3 more
-
Bangkok, Thailand
- +1 more
Feb 15, 2022
HIV-1 Trial in Worldwide (Ad26.Mos4.HIV, Clade C gp140, Placebo)
Completed
- HIV-1
- Ad26.Mos4.HIV
- +2 more
-
Lilongwe, Malawi
- +22 more
Apr 12, 2022
Cytomegalovirus Infections Trial (V160 Low Dose IM, V160 Medium Dose IM, V160 High Dose IM)
Completed
- Cytomegalovirus Infections
- V160 Low Dose IM
- +8 more
- (no location specified)
Sep 30, 2021
Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)
Active, not recruiting
- Healthy
- Ad26.Mos4.HIV
- +2 more
-
Birmingham, Alabama
- +52 more
Jan 17, 2023
Covid19 Trial in Halifax, Ottawa, Toronto (VBI-2902a, Placebo, VBI-2905a)
Active, not recruiting
- Covid19
- VBI-2902a
- +2 more
-
Halifax, Nova Scotia, Canada
- +3 more
Jul 18, 2022
Pneumococcal Disease, Invasive Trial in Denpasar (Walvax PCV13-TT, Pfizer PCV13)
Not yet recruiting
- Pneumococcal Disease, Invasive
- Walvax PCV13-TT
- Pfizer PCV13
-
Denpasar, Bali, IndonesiaDepartemen Ilmu Kesehatan Anak FK Unud
Jun 28, 2023
Healthy Trial in Rwanda, United States (Ad26.Mos.HIV, Ad26.Mos4.HIV, Clade C gp140)
Completed
- Healthy
- Ad26.Mos.HIV
- +3 more
-
Birmingham, Alabama
- +9 more
Jul 5, 2022
HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine
Recruiting
- HIV Infections
- Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
- +3 more
-
Columbus, Ohio
- +1 more
Apr 10, 2022
Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos4.HIV
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 7, 2022
Esophageal Stenosis Acquired Trial in Beijing (Hydrocortisone sodium succinate mixed with Aluminium Phosphate gel (route of
Completed
- Esophageal Stenosis Acquired
- Hydrocortisone sodium succinate mixed with Aluminium Phosphate gel (route of administration)
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jan 18, 2021
COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)
Recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901a
-
Halifax, Nova Scotia, Canada
- +6 more
Nov 16, 2022
Acute Gastroenteritis Trial in Liuzhou (Low-dose vaccine, High-dose vaccine, Placebo (containing aluminum))
Recruiting
- Acute Gastroenteritis
- Low-dose vaccine
- +3 more
-
Liuzhou, Guangxi, ChinaLiuzhou Center for Disease Control and Prevention
Sep 2, 2022
Pneumococcal Infections Trial in Zhengzhou (Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine, Control
Not yet recruiting
- Pneumococcal Infections
- Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
- +2 more
-
Zhengzhou, Henan, ChinaHenan Center for Diseases Control and Prevention
Oct 13, 2021
COVID-19 Trial in Dubai (Recombinant two-component COVID-19 vaccine (CHO cell), COVID-19 Vaccine (Vero Cell), Inactivated)
Recruiting
- COVID-19
- Recombinant two-component COVID-19 vaccine (CHO cell)
- COVID-19 Vaccine (Vero Cell), Inactivated
-
Dubai, United Arab EmiratesAI Kuwait Hospital
Sep 29, 2022
Group B Streptococcal Infections Trial in Stockbridge, Bardstown, Salt Lake City (Group B streptoccous 6-valent polysaccharide
Completed
- Group B Streptococcal Infections
- Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)
-
Stockbridge, Georgia
- +3 more
Oct 11, 2021
H7N9 Influenza Trial in Zhumadian (7.5µg H7N9 Vaccine, Phosphate Buffer Solution, Aluminum Hydroxide Adjuvant)
Unknown status
- H7N9 Influenza
- 7.5μg H7N9 Vaccine
- +4 more
-
Zhumadian, Henan, ChinaSuiping Center for Disease Control and Prevention
Mar 20, 2019
Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)
Not yet recruiting
- Chronic HIV Infection
- 426c.Mod.Core-C4b
- Adjuvant 3M-052-AF+Alum
-
Birmingham, Alabama
- +6 more
Aug 17, 2023
Cutaneous Lupus Trial in Orlando (532nm laser, 1064nm laser, Topical corticosteroid)
Terminated
- Cutaneous Lupus
- 532nm laser
- +2 more
-
Orlando, FloridaUCF Health Lake Nona Office
Jun 29, 2021
Anemia of Chronic Kidney Disease Trial in Taiwan (Ferric citrate, Placebo)
Recruiting
- Anemia of Chronic Kidney Disease
- Ferric citrate
- Placebo
-
Kaohsiung, Taiwan
- +7 more
Mar 6, 2022
Root Caries Trial (S-PRG barrier coat)
Not yet recruiting
- Root Caries
- S-PRG barrier coat
- (no location specified)
Aug 19, 2022
HPV Infection Vaccine Safety SCT1000 Trial in Nanjing (SCT1000, Gardasil®9, )
Recruiting
- HPV Infection Vaccine Safety SCT1000
- SCT1000
- +3 more
-
Nanjing, Jiangsu, ChinaGuanyun Country CDC
Sep 14, 2021
Insemination, Artificial Trial in Saint-Étienne (samples of sperm)
Completed
- Insemination, Artificial
- samples of sperm
-
Saint-Étienne, FranceCHU de Saint Etienne
Mar 10, 2022